TRAVERE THERAPEUTICS, INC. Foreign Currency Transaction Gain (Loss), Realized
TRAVERE THERAPEUTICS, INC. (TVTX) reported Foreign Currency Transaction Gain (Loss), Realized of $2.60 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-10-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2022-10-27
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2022-09-30 was $2.60M, a 1101.85% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2022-06-30 was $1.42M.
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2022-03-31 was $71.00K, a 93.56% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for the quarter ending 2021-09-30 was $216.00K.
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for fiscal 2018 was $39.00K.
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for fiscal 2017 was -$339.00K, a 464.52% decline from fiscal 2016.
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for fiscal 2016 was $93.00K.
- TRAVERE THERAPEUTICS, INC. foreign currency transaction gain (loss), realized for fiscal 2015 was -$40.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 3 month as first filed | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month | Foreign Currency Transaction Gain (Loss), Realized 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-09-30 | $2.60M 10-Q · filed 2022-10-27 | $4.01M derived: sum of 2 quarters · filed 2022-10-27 | $4.08M 10-Q · filed 2022-10-27 | |||
| 2022-06-30 | $1.42M 10-Q · filed 2022-08-04 | $1.49M 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | $71.00K 10-Q · filed 2022-05-05 | |||||
| 2021-09-30 | $216.00K 10-Q · filed 2022-10-27 | -$11.00K derived: sum of 2 quarters · filed 2022-10-27 | $1.09M 10-Q · filed 2022-10-27 | |||
| 2021-06-30 | -$227.00K 10-Q · filed 2022-08-04 | $875.00K 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-05 | |||||
| 2020-09-30 | -$564.00K 10-Q · filed 2021-10-29 | -$811.00K derived: sum of 2 quarters · filed 2021-10-29 | -$620.00K 10-Q · filed 2021-10-29 | |||
| 2020-06-30 | -$247.00K 10-Q · filed 2021-07-29 | -$56.00K 10-Q · filed 2021-07-29 | ||||
| 2020-03-31 | $191.00K 10-Q · filed 2021-05-06 | |||||
| 2019-09-30 | $315.00K 10-Q · filed 2020-11-05 | $224.00K derived: sum of 2 quarters · filed 2020-11-05 | $342.00K 10-Q · filed 2020-11-05 | $351.00K derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | -$91.00K 10-Q · filed 2020-07-31 | $27.00K 10-Q · filed 2020-07-31 | $36.00K derived: sum of 3 quarters · filed 2020-07-31 | $41.00K derived: sum of 4 quarters · filed 2020-07-31 | ||
| 2019-03-31 | $117.00K 10-Q · filed 2020-05-11 | $127.00K derived: sum of 2 quarters · filed 2020-05-11 | $132.00K derived: sum of 3 quarters · filed 2020-05-11 | $134.00K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $15.00K derived: sum of 2 quarters · filed 2019-10-30 | $17.00K derived: sum of 3 quarters · filed 2019-10-30 | $39.00K 10-K · filed 2019-02-26 | ||
| 2018-09-30 | $5.00K 10-Q · filed 2019-10-30 | $7.00K derived: sum of 2 quarters · filed 2019-10-30 | $29.00K 10-Q · filed 2019-10-30 | $51.00K derived: sum of 4 quarters · filed 2019-10-30 | ||
| 2018-06-30 | $2.00K 10-Q · filed 2019-08-06 | $24.00K 10-Q · filed 2019-08-06 | $46.00K derived: sum of 3 quarters · filed 2019-08-06 | -$56.00K derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-03-31 | $22.00K 10-Q · filed 2019-05-07 | $44.00K derived: sum of 2 quarters · filed 2019-05-07 | -$58.00K derived: sum of 3 quarters · filed 2019-05-07 | -$241.00K derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2017-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$80.00K derived: sum of 2 quarters · filed 2019-02-26 | -$263.00K derived: sum of 3 quarters · filed 2019-02-26 | -$339.00K 10-K · filed 2019-02-26 | ||
| 2017-09-30 | -$102.00K 10-Q · filed 2018-11-01 | -$285.00K derived: sum of 2 quarters · filed 2018-11-01 | -$361.00K 10-Q · filed 2018-11-01 | -$287.00K derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | -$183.00K 10-Q · filed 2018-08-03 | -$259.00K 10-Q · filed 2018-08-03 | -$185.00K derived: sum of 3 quarters · filed 2019-02-26 | -$168.00K derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | -$76.00K 10-Q · filed 2018-07-06 | -$2.00K derived: sum of 2 quarters · filed 2019-02-26 | $15.00K derived: sum of 3 quarters · filed 2019-02-26 | $86.00K derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $91.00K derived: sum of 2 quarters · filed 2019-02-26 | $162.00K derived: sum of 3 quarters · filed 2019-02-26 | $93.00K 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $17.00K 10-Q · filed 2017-11-07 | $88.00K derived: sum of 2 quarters · filed 2017-11-07 | $19.00K 10-Q · filed 2017-11-07 | -$29.00K derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2016-06-30 | $71.00K 10-Q · filed 2017-08-09 | $2.00K 10-Q · filed 2017-08-09 | -$46.00K derived: sum of 3 quarters · filed 2018-07-06 | -$32.00K derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2016-03-31 | -$69.00K 10-Q · filed 2017-05-05 | -$117.00K derived: sum of 2 quarters · filed 2018-07-06 | -$103.00K derived: sum of 3 quarters · filed 2018-07-06 | -$133.00K derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2015-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | -$34.00K derived: sum of 2 quarters · filed 2018-07-06 | -$64.00K derived: sum of 3 quarters · filed 2018-07-06 | -$40.00K 10-K · filed 2018-07-06 | ||
| 2015-09-30 | $14.00K 10-Q · filed 2016-11-04 | -$16.00K derived: sum of 2 quarters · filed 2016-11-04 | $8.00K 10-Q · filed 2016-11-04 | $7.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | -$30.00K 10-Q · filed 2016-08-05 | -$7.00K 10-Q · filed 2016-08-05 | -$7.00K derived: sum of 3 quarters · filed 2017-03-01 | -$7.00K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $23.00K 10-Q · filed 2016-05-05 | $23.01K 10-Q · filed 2015-05-11 | $23.00K derived: sum of 2 quarters · filed 2017-03-01 | $23.00K derived: sum of 3 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | $2.38K 10-K · filed 2015-03-11 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | ||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 | -$3.87K 10-K · filed 2015-03-11 | ||||
| 2012-12-31 | -$2.75K 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |